相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients
Josephine Ocran-Appiah et al.
VACCINE (2021)
Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
Nicolas Lecrenier et al.
EXPERT REVIEW OF VACCINES (2018)
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
Anthony L. Cunningham et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study
Roger Baxter et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases
Xin-Xing Gu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
A. L. Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Himal Lal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Long-term Persistence of Zoster Vaccine Efficacy
Vicki A. Morrison et al.
CLINICAL INFECTIOUS DISEASES (2015)
Systematic review of incidence and complications of herpes zoster: towards a global perspective
Kosuke Kawai et al.
BMJ OPEN (2014)
THE GLOBAL EPIDEMIOLOGY OF HERPES ZOSTER
Barbara P. Yawn et al.
NEUROLOGY (2013)
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
MN Oxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
What does epidemiology tell us about risk factors for herpes zoster?
SL Thomas et al.
LANCET INFECTIOUS DISEASES (2004)
分享论文
